Module Pre- & Posttest Ranks | |||
---|---|---|---|
Median (Interquartile Range) | |||
Question | Pretest | Posttest | p-value |
Student Background | |||
How satisfied are you with the amount of OP training that you have received in your formal education thus far? | 3 (2) | 4 (1) | < 0.001 |
General Learning Objectives | |||
I understand the risks of opioids in chronic PM. | 4 (0) | 4 (1) | < 0.002 |
I understand the benefits of opioids in chronic PM. | 4 (0) | 4 (1) | < 0.001 |
I understand when it is appropriate to prescribe opioids for chronic PM. | 3 (1) | 4 (1) | < 0.001 |
I understand the risks of opioids in acute PM. | 4 (0) | 5 (1) | < 0.001 |
I understand the benefits of opioids in acute PM. | 4 (0) | 5 (1) | < 0.001 |
I understand when it is appropriate to prescribe opioids for acute PM. | 3 (2) | 4 (1) | < 0.001 |
I am familiar with the types of opioid medications used for PM. | 4 (1) | 4 (1) | < 0.001 |
I am familiar with the types of non-opioid medications used for PM. | 4 (0) | 5 (1) | < 0.001 |
I understand the role of prescription opioids in the opioid epidemic. | 4 (1) | 5 (1) | < 0.001 |
I am familiar with the Prescription Drug Monitoring Program and know when to use it. | 4 (1) | 5 (1) | < 0.001 |
I am familiar with OP guidelines (i.e. dosages and amounts to prescribe). | 2 (1) | 4 (0) | < 0.001 |
Case #1 | |||
I understand the differences in OP for older adults (> 65) vs. adults (< 65). | 2 (1) | 4 (1) | < 0.001 |
I understand the complexities of pain assessment in patients with dementia. | 3 (2) | 4 (1) | < 0.001 |
I understand the differences between nociceptive, neuropathic and inflammatory pain. | 4 (1) | 5 (1) | < 0.001 |
I am familiar with the risks and benefits of commonly used pain medications for older adults (> 65). | 3 (2) | 5 (1) | < 0.001 |
I am familiar with safe PM strategies for older adults (> 65). | 3 (2) | 4 (1) | < 0.001 |
Case #2 | |||
I understand the differences in treating nociceptive, neuropathic and inflammatory pain. | 3 (2) | 5 (1) | < 0.001 |
I am familiar with first-line treatments and strategies for chronic PM. | 3 (2) | 5 (1) | < 0.001 |
I understand the concept of “opioid diversion.” | 3 (2) | 5 (1) | < 0.001 |
I am familiar with safe strategies for disposing of unused opioids. | 2 (2) | 5 (1) | < 0.001 |
Case #3 | |||
I am familiar with the risk factors for patient opioid misuse. | 4 (1) | 5 (1) | < 0.001 |
I am familiar with safe management strategies for patients on long-term opioid treatment for chronic pain. | 2 (1) | 4 (1) | < 0.001 |
I understand the concept of opioid tapering. | 4 (1) | 4 (1) | < 0.001 |
I understand the concept of morphine milligram equivalents (MMEs). | 4 (2) | 5 (1) | < 0.001 |
I understand how to convert morphine milligram equivalents (MMEs). | 2 (3) | 5 (1) | < 0.001 |
I am familiar with the symptoms of an opioid overdose. | 4 (1) | 5 (1) | < 0.005 |
I understand the role of naloxone in opioid overdose. | 5 (1) | 5 (0) | < 0.002 |
I understand the importance of co-prescribing naloxone with opioids. | 4 (1) | 5 (0) | < 0.001 |
Case #4 | |||
I understand the role of medication-assisted treatment (MAT) in patients with OUD. | 4 (1) | 5 (0) | < 0.001 |
I understand the differences between methadone, buprenorphine, and naltrexone. | 4 (1) | 5 (1) | < 0.001 |
I understand the concept of patient-controlled analgesia (PCA). | 4 (0) | 5 (1) | < 0.001 |
I am familiar with the differences in opioid dosing requirements for opioid-tolerant vs. opioid-naive patients. | 3 (2) | 4 (1) | < 0.001 |
Case #5 | |||
I understand the danger of co-prescribing benzodiazepines and opioids. | 4 (1) | 5 (0) | < 0.001 |
I understand the role of multimodal analgesia in PM. | 4 (0) | 5 (1) | < 0.001 |
Case #6 | |||
I understand the differences in pain medication dosing for the pediatric vs. adult population. | 2 (1) | 4 (1) | < 0.001 |
I am familiar with the risks of prescribing opioids to adolescents for PM. | 4 (2) | 4 (1) | < 0.001 |
Case #7 | |||
I am familiar with pain medications that are safe for pregnant patients. | 2 (2) | 4 (2) | < 0.001 |
I am familiar with safe opioid management strategies for pregnant patients. | 2 (1) | 4 (1) | < 0.001 |
I understand the postnatal effects of opioids on neonates. | 4 (0) | 5 (1) | < 0.001 |
Case #8 | |||
I am familiar with the concept of pain syndromes in cancer survivors. | 3 (2) | 4 (1) | < 0.001 |
I understand the role of opioids in chronic cancer pain. | 4 (1) | 4 (1) | < 0.001 |
Student Perceived Competence | |||
I am confident in my ability to manage opioids for patient pain. | 2 (1) | 4 (0) | < 0.001 |
I am capable of managing opioids for patient pain. | 2 (1) | 4 (0) | < 0.001 |
I am able to provide opioid management for patient pain. | 2 (2) | 4 (0) | < 0.001 |
I am able to meet the challenge of opioid management for patient pain. | 3 (2) | 4 (0) | < 0.001 |
Overall score | 150 (24) | 206 (25) | < 0.001 |